Progesterone for premenstrual syndrome

Cochrane Database of Systematic Reviews

Volumn , Issue 2, 2009, Pages

  Ford, Olive ^a   Lethaby, Anne ^b   Roberts, Helen ^b   Mol, Ben Willem J ^a  

^a University of Auckland ^*  (Netherlands)

^b NATIONAL WOMEN S HOSPITAL   (New Zealand)

Author keywords

Female; Humans; Premenstrual syndrome *prevention control ; Progesterone adverse effects; *therapeutic use ; Progestins *therapeutic use ; Randomized controlled trials as topic

Indexed keywords

PROGESTERONE;

ABDOMINAL PAIN; CLINICAL TRIAL; DEPRESSION; DIARRHEA; DIZZINESS; DROWSINESS; DRUG EFFICACY; DYSMENORRHEA; HEADACHE; HUMAN; INFLUENZA; LUTEAL PHASE; MASTALGIA; MENSTRUAL CYCLE; MENSTRUAL IRREGULARITY; MOOD DISORDER; MULTIPLE CYCLE TREATMENT; NAUSEA; OVARY CYST; PREMENSTRUAL SYNDROME; RECTUM INJURY; REVIEW; SYSTEMATIC REVIEW; THYROTOXICOSIS; TREATMENT DURATION; VAGINAL DISCOMFORT; VAGINAL PRURITUS;

EID: 70349101701     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD003415.pub3     Document Type: Review

References (93)

1. Magill PJ. Investigation of the efficacy of progesterone pessaries in the relief of symptoms of premenstrual syndrome. British Journal of General Practice 1995;45(400):589-593
2. Vaneslow W, Dennerstein L, Greenwood KM, de Lignieres B. Effect of progesterone and its 5 alpha and 5 beta metabolites on symptoms of premenstrual syndrome according to route of administration. Journal of Psychosomatic Obstetrics and Gynaecology 1996;17(1):29-38. (Pubitemid 26144132)
3. Andersch B Hahn L. Progesterone treatment of premenstrual tension - a double blind study. Journal of Psychosomatic Research 1985;29(5):489-493 (Pubitemid 16219167)
4. Baker ER, Best RG, Manfredi RL, Demers LM, Wolf GC. Efficacy of vaginal suppositories in alleviation of nervous symptoms in patients with premenstrual syndrome. Journal of Assisted Reproduction and Genetics 1995;12(3):205-209
5. Corney RH, Stanton R, Newell R. Comparison of progesterone, placebo and behavioural psychotherapy in the treatment of premenstrual syndrome. Journal of Psychosomatic Obstetrics and Gynaecology 1990;11:211-220 (Pubitemid 20282069)
6. Dennerstein L, Spencer-Gardener C, Gotts G, Brown JB, Smith MA, Burrows GD. Progesterone and the premenstrual syndrome: a double blind crossover trial. British Medical Journal (Clinical Research Ed.) 1985;290(6482):1617-1621 (Pubitemid 15062630)
7. * Freeman E, Rickels K, Sondheimer SJ, Polansky M. Ineffectiveness of progesterone suppository treatment for premenstrual syndrome. JAMA 1990;264(3):349-353
8. Freeman EW, Rickels K, Sondheimer SJ. Course of premenstrual syndrome symptom severity after treatment. American Journal of Psychiatry 1992;149(4):531-533
9. Freeman E W, Rickels K, Sondheimer SJ, Polansky M. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. JAMA 1995;274(1):51-57
10. Gray LA. The use of progesterone in nervous tension states. Southern Medical Journal 1941;34(9):1004-1006
11. Maddocks S, Hahn P, Moller F, Reid RL. A double-blind placebo-controlled trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome. American Journal of Obstetrics and Gynecology 1986;154(3):573-581 (Pubitemid 16128022)
12. Rapkin A, Chang L H, Reading AI. Premenstrual syndrome:a double blind trial of treatment with progesterone vaginal suppositories. Journal of Obstetrics and Gynecology 1987;7(3):217-220 (Pubitemid 17003424)
13. Richter MA, Halvic R, Shapiro SS. Progesterone treatment of premenstrual syndrome. Current Therapeutic Research 1984;36(5):840-850
14. Sampson GA. Premenstrual syndrome: a double-blind controlled trial of progesterone and placebo. British Journal of Psychiatry 1979;135:209-215 (Pubitemid 9244804)
15. * Smith SL. Mood and the menstrual cycle. In: Sachar, E J editor (s). Topics in psychoendocrinology. New York: Grune and Stratton, Raven Press, 1975:19-58.
16. van der Meer YG, Benedek-Jaszmann LJ, van Loenan AC. Effect of high dose progesterone on the premenstrual syndrome: a double blind crossover trial. Journal of Psychosomatic Obstetrics and Gynecology 1983;2:220-222
17. * Vargyas JM, Marrs RP. The use of progesterone in the premenstrual syndrome. Proceeding of the 41st Annual Meetoing of the American Fertility Society: [Abstract No.2] in Abstracts in Endocrinology.. 1985.
18. Association of the British Pharmaceutical Industry (ABPI). Compendium of data sheets and summaries of product characteristics 1998-99. London: Datapharm Publications Limited, 1999.
19. Abplanalp JM. Psychological components of the premenstrual syndrome. Evaluating the research and choosing the treatment. Journal of Reproductive Medicine 1979;28(8):517-524
20. Altman DG, Schulz K F, Moher D, Egger M, Davidoff F, Elbourne D, et al.The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Annals of Internal Medicine 2001;134(8):663-694 (Pubitemid 32322245)
21. Andersch B, Abrahamsson L, Wendestam C, Ohman R, Hahn L. Hormone profile in premenstrual tension: effects of bromocriptine and diuretics. Clinical Endocrinology 1979;11(6):657-664 (Pubitemid 10214362)
22. Backstrom T, Mattsson B. Correlation of symptoms in pre-menstrual tension to oestrogen and progesterone concentrations in blood plasma. A preliminary study. Neuropsychobiology 1975;1(2):80-86
23. Backstrom T, Andreen L, Birzniece V, Bjorn I, Johansson IM, Nordenstam-Haghjo M, et al.The role of hormones and hormonal treatments in premenstrual syndrome. CNS Drugs 2003;17(5):325-342 (Pubitemid 36469971)
24. Björn I, Sundströme-Poromaa, Bixo M, Nyberg S, Bäckström G, Bäckström T. Increase of estrogen dose deteriorates mood during progestin phase in sequential hormonal therapy.. The Journal of Clinical Endocrinology and Metabolism 2003;88(5):2026-2030 (Pubitemid 36553110)
25. Chakmakjian ZH, Zachariah NY. Bioavailability of progesterone with different methods of administration. Journal of Reproductive Medicine 1987;32:443-448
26. Chisholm G, Jung SO, Cumming CE, Fox EE, Cumming DC. Premenstrual anxiety and depression: comparison of objective psychological tests with a retrospective questionnaire. Acta Psychiatrica Scandinavica 1990;81(1):52-57 (Pubitemid 20096988)
27. Collin D, Gandar R. The corpus luteum and progesterone secretion [Corps jaune et secretion de progesterone]. Revue Française de Gynécologie et d Obstétrique 1991;86(10):563-565
28. Corvol P, Elkik F, Feneant M, Oblin ME, Michaud A, Claire M, et al.Effect of progesterone and progestins on water and salt metabolism. In: Bardin CW, Milgrom E, Mauvais-Jarvis P editor(s). Progesterone and Progestins. New York: Raven Press, 1983:179-186
29. Dalton K. Progesterone suppositories and pessaries in the treatment of menstrual migraine. Headache 1973;12(4):151-159
30. Dalton K. Migraine in general practice. Journal of the Royal College of General Practitioners 1973;23(127):97-106.
31. Dalton K. The premenstrual syndrome and progesterone therapy. London: Heinemann Medical Books, 1977.
32. Dalton. Premenstrual syndrome and progesterone therapy. London: Heinemann Medical, 1984.
33. Dalton K, Holton D. PMS: The essential guide to treatment options. Northampton: Thorsons (imprint of Harper Collins), 1994.
34. American Psychiatric Association. Diagnostic and statisticalmanual of mental disorders 3rd ed. rev. Washington DC: American Psychiatric Association, 1987.
35. American Psychiatric Association. Diagnostic and statistical manual of mental disorders 4th ed. Washington DC: American Psychiatric Association, 1994.
36. Endicott J, Halbreich U. Retrospective reports of premenstrual changes: factors affecting confirmation of daily ratings. Psychopharmacology Bulletin 1982;16:109-112 (Pubitemid 13211170)
37. Facchinetti F, Genazzani AD, Martignoni E, Fioroni L, Sances G, Genazzani AR. Neuroendocrine correlates of premenstrual syndrome: changes in the pulsatile pattern of plasma LH. Psychoneuroendocrinology 1990;15(4):269-277
38. Facchinetti F, Genazzani AD, Martignoni E, Fioroni L, Nappi G, Genazzani AR. Neuroendocrine changes in luteal function in patients with premenstrual syndrome. Journal of Clinical Endocrinology and Metabolism 1993;76(5):1123-1127 (Pubitemid 23155423)
39. Frank RT. The hormonal causes of premenstrual tension. Archives of Neurology and Psychiatry 1931;26:1053-1057
40. Freeman EW, DeRubeis RJ, Rickels K. Reliability and validity of a daily diary for premenstrual syndrome. Psychiatry Research 1996;65(2):97-106. (Pubitemid 27052335)
41. Freeman EW, Rickels K. Characteristics of placebo responses in medical treatment of premenstrual syndrome. American Journal of Psychiatry 1999;156(9):1403-1408 (Pubitemid 29416538)
42. Garcia-Berthou E, Alcaraz C. Incongruence between test statistics and P values in medical papers. Medical Research Methodology 2004;4:13. (Pubitemid 39319729)
43. Greene R, Dalton K. The premenstrual syndrome. British Medical Journal 1953;1:1007-1014
44. Halbreich U, Endicott J. Methodological issues in studies of premenstrual changes. Psychoneuroendocrinology 1985;10(1):15-32. (Pubitemid 15108252)
45. Halbreich U, Endicott J, Goldstein S, Nee J. Premenstrual changes and changes in gonadal hormones. Acta Psychiatrica Scandinavica 1986;74(6):576-586
46. Halbreich U, O'Brien P M S, Erikksson E, Bäckström T, Yonkers K A, Freeman E W. Are there different symptom proflies that improve in response to different pharmacological treatments of premenstrual syndrome/premenstrual dysphoric disorder?. Drugs 2006;20(7):523-547 (Pubitemid 43990532)
47. Halbreich U, Bäckström T, Eriksson E, O'Brien P M S, Calil H, Ceskova E, Dennerstein L, Douki S, Freeman E, Genazzani A, Heuser I, Kadri N, Rapkin A, Steiner M, Wittchen H-U, Yonkers K. Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies. Gynecological Enocrinology 2007;23(3):123-130 (Pubitemid 46570210)
48. Hammarbäck S, Damber JE, Backstrom T. Relationship between symptom severity and hormone changes in women with premenstrual syndrome. Journal of Clinical Endocrinology and Metabolism 1989;68(1):125-130 (Pubitemid 19028734)
49. Hargrove JT, Maxson WS, Wentz AC. Absorption of oral progesterone is influenced by vehicle and particle size. American Journal of Obstetrics and Gynecology 1989;161(4):948-951 (Pubitemid 19266207)
50. Haywood A, Slade P, King H. Assessing the assessment measures for menstrual cycle symptoms: a guide for researchers and clinicians. Journal of Psychosomatic Research 2002;52(4):223-237 (Pubitemid 34477083)
51. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials.. BMJ 1999;319(7211)):670-674 (Pubitemid 29423954)
52. Horney K. Premenstrual tension. In: Kelman, H editor(s). Feminine Psychology.. New York: WW Norton, 1931:99-106.
53. Johnson JM. Visual Analog scales: Part 1, 2 and 3. DCI Research Review 2004.
54. Johnson, S R. Premenstrual syndrome, premenstrual dysphoric disorder, and beyond: a clinical primer for practitioners. Obstetrics and Gynecology 2004;104(4):845-859 (Pubitemid 40458816)
55. Keenan PA, Lindamer LA, Jong SK. Psychological aspects of premenstrual syndrome. II: Unity of standardized measures. Psychoneuroendocrinology 1992;17(2-3):189-194
56. Kienle GS, Kiene H. Placebo effect and placebo concept: a critical methodological and conceptual analysis of reports on the magnitude of the placebo effect.. Alternative Therapies in Health and Medicine 1996;2(6):39-54. (Pubitemid 126466083)
57. Klatzkin R R, Morrow L A, Light K C, Pedersen C A, Girdler S S. Associations of histories of depression and PMDD diagnosis with allopregnanolone concnetrations following the oral administration of micronised progesterone.. Psychoneuroendocrinology 2006;31:1208-1219
58. Knaapen L, Weisz G. The biomedical standardisation of premenstrual syndrome.. Studies in History and Philosophy of Biological and Biomedical Sciences 2008;39:120-134
59. Landau RL, Lugibihl K. Inhibition of the sodium-retaining influence of aldosterone by progesterone. Journal of Clinical Endocrinology and Metabolism 1958;18(11):1237-1245
60. Landen M, Eriksson E. How does premenstrual dysphoric disorder relate to depression and anxiety disorders?. Depression and Anxiety 2003;17(3):122-129 (Pubitemid 36644710)
61. Lewis LL, Greenblatt EM, Rittenhouse CA, Veldhuis JD, Jaffe RB. Pulsatile release patterns of luteinizing hormone and progesterone in relation to symptom onset in women with premenstrual syndrome. Fertility and Sterility 1995;64(2):288-292
62. Lovick, TA. Plasticity of GABAA receptor subunit expression during the oestrous cycle of the rat: implications for premenstrual syndrome in women. Experimental Physiology 2006;91(4):655-660
63. Lovick T A. GABA in the female brain - Oestrous cycle-related changes in GABAergic function in the periaqueductal grey matter.. Biochemistry and Behaviour 2008;90:43-50.
64. Magill P J. Personal communication 01/11/2004.
65. Monteleone P, Luisi S, Tonetti A, Bernardi F, Genazzani AD, Luisi M, et al.Allopregnanolone concentrations and premenstrual syndrome. European Journal of Endocrinology 2000;142(3):269-273
66. Moos R H. The development of a menstrual distress questionnaire. Psychosomatic Medicine 1968;30(6):853-867
67. Moos RH. Typology ofmenstrual cycle symptoms. American Journal of Obstetrics and Gynecology 1969;103(3):390-402.
68. Morville R, Dray F, Reynier J, Barratt J. The bioavailability of natural progesterone given by mouth. Measurement of steroid concentration in plasma, endometrium and breast tissue [Biodisponibilitée de la progesterone naturelle administréee par voie orale]. Journal de Gynécologie obstétrique et biologie de reproduction [Paris] 1982;11:355-363
69. Nyberg S, Backstrom T, Zingmark E, Purdy RH, Poromaa I S. Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome.. Gynecological endocrinology 2007;23(5):257-266 (Pubitemid 46897697)
70. O'Brien PM, Selby C, Symonds EM. Progesterone, fluid and electrolytes in premenstrual syndrome. British Medical Journal 1980;280(6224):1161-1163 (Pubitemid 10116201)
71. O'Brien PM. Helping women with premenstrual syndrome. BMJ 1993;307(6917):1471-1475
72. Price JH, Ismaeil H, Gorwill RH, Sarda IR. Effect of suppository base on progesterone delivery from the vagina.. Fertility and Sterility 1983;39(4):490-493
73. Redei E, Freeman EW. Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms. Psychoneuroendocrinology 1995;20(3):259-267
74. Rees L.The premenstrual tension syndrome and its treatment. British Medical Journal 1953;1(4818):1014-1016
75. Rubinow DR, Hoban MC, Grover GN, Galloway DS, Roy-Byrne P, Andersen R, et al.Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. American Journal of Obstetrics and Gynecology 1988;158(1):5-11. (Pubitemid 18043325)
76. Seippel L, Eriksson O, Grankvist K, von Shoultz B, Backstrom T. Physical symptoms in premenstrual syndrome are related to plasma progesterone and desoxycorticosterone. Gynecological Endocrinology 2000;14(3):173-181 (Pubitemid 30449894)
77. Smith SS, Gong QH, Hsu FC, Markowitz RS, ffrench-Mullen JM, Li X. GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 1998;392(6679):926-930
78. Steele PA, Braund W, Judd SJ. Regulation of pulsatile secretion of progesterone during the human luteal phase. Clinical Reproduction and Fertility 1986;4(2):117-124 (Pubitemid 17172185)
79. Steiner M, Haskett RF, Carroll BJ. Premenstrual tension syndrome: the development of research diagnostic criteria and new rating scales.. Acta Psychiatrica Scandinavica 1980;62(2):177-190 (Pubitemid 10045563)
80. Steiner M. Premenstrual syndrome and premenstrual dysphoric disorder: guidelines for management. Journal of Psychiatry and Neuroscience 2000;25(5):459-468 (Pubitemid 32059915)
81. Stout EL, Steege JF. Psychological assessment of women seeking treatment for premenstrual syndrome. Journal of Psychosomatic Research 1985;29(6):621-629 (Pubitemid 16203311)
82. Sveinsdottir H. Prospective assessment of menstrual and premenstrual experiences of Icelandic women. Health Care for Women International 1998;19(1):71-82. (Pubitemid 128447914)
83. Taylor RJ, Alexander DA, Fordyce ID. A survey of paramenstrual complaints by covert and by overt methods. Journal of the Royal College of General Practitioners 1986;36(292):496-499
84. Thys-Jacobs S, McMahon D, Bilezikian J P. Differences in free estradiol and sex hormone-binding globulin in women with and without premenstrual dysphoric disorder. Journal of Clinical Endocrinology and Metabolism 2008;93(1):96-102.
85. van der Meer YG, van Loenen AC, Loendersloot EW, Jaszmann LJ. Plasma progesterone concentrations after high-dose suppositories. A preliminary report.. Pharmaceutisch Weekblad Scientific edition 1982;4(5):135-136
86. Vanselow W. Personal correspondence 15/12/05.
87. Walker AF, De Souza MC, Marakis G, Robinson PA, Morris AP, Bolland KM. Unexpected benefit of sorbitol placebo in Mg intervention study of premenstrual symptoms: implications for choice of placebo in RCTs. Medical Hypotheses 2002;58(3):213-220 (Pubitemid 34664892)
88. Wang M, Seippel L, Purdy RH, Bäckström T. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3, 20-dione and 3 alpha-hydroxy-5 alpha- pregnan-20-one. Journal of Clinical Endocrinology and Metabolism 1996;81(3):1076-1082 (Pubitemid 126423246)
89. Watanabe H, Lau DC, Guyn HL, Wong NL. Effect of progesterone therapy on arginine vasopressin and atrial natriuretic factor in premenstrual syndrome. Clinical & Investigative Medicine - Médecine clinique et expérimentale 1997;20(4):211-223 (Pubitemid 27376132)
90. Wendestam 1980. Mental changes in the premenstrual phase. A study of the psycho-pathological profile, its prevalence and its hormonal correlations [Thesis]. Sweden: University of Gotenberg 1980.
91. Wyatt K, Dimmock P, Jones P, Obhrai M, O'Brien S. Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review. BMJ 2001;323(7316):776-780 (Pubitemid 32946762)
92. Wyatt KM, Dimmock PW, Hayes-Gill B, Crowe J, O'Brien PM. Menstrual symptometrics: a simple computer-aided method to quantify menstrual cycle disorders. Fertility and Sterility 2002;78(1):96-101. (Pubitemid 34722677)
93. Ford O, Lethaby A, Roberts H, Mol BWJ. Progesterone for premenstrual syndrome DOI: 10.1002/14651858.CD003415.pub2.. Cochrane Database of Systematic Reviews 2006, Issue 4. [DOI: 10.1002/14651858] (Pubitemid 46841296)